Allergan, TPG Said to Consider Valeant Eye-Surgery Assets

Allergan, TPG Said to Consider Valeant Eye-Surgery Assets


Allergan Plc and buyout firm TPG are among potential suitors weighing a bid for Valeant Pharmaceuticals International Inc.'s eye-surgery assets, according to people familiar with the matter. The surgical products, which are part of Valeant's Bausch & Lomb unit, have also attracted early interest from Germany's Carl Zeiss Meditec AG, as well as other private equity firms and possible bidders in Asia, one of the people said, asking not to be identified as the details aren't public.



from Biotech News